News | Quality Assurance (QA) | October 25, 2020

Sun Nuclear Presents Updated and Comprehensive Quality Management Solutions at ASTRO20

During the 2020 ASTRO Annual Meeting, taking place online October 23-29, Sun Nuclear is highlighting a range of solutions clinics can leverage to ensure continuity for their Quality Management programs.

October 25, 2020 — During the 2020 ASTRO Annual Meeting, taking place online October 23-29, Sun Nuclear is highlighting a range of solutions clinics can leverage to ensure continuity for their Quality Management programs. Sun Nuclear's integrated, independent QA solutions span Patient Alignment, Patient QA, Machine QA, Dosimetry and Diagnostic QA. ASTRO attendees are invited to explore the Sun Nuclear virtual booth in the Exhibit Hall to learn more.

Remote QA readiness is a central theme in the Sun Nuclear ASTRO booth. Clinics worldwide report the SunCHECK Platform has proven essential to their COVID-19 preparedness, and critical to ongoing operations. Quick videos and resources in our booth explain how Radiation Oncology departments can and have leveraged SunCHECK for consistent, collaborative and remote QA.

"Many Radiation Oncology teams have reached out to us this year in need of efficient and remote-capable workflow solutions. I'm pleased to say our comprehensive solutions were ready to fill that gap, particularly with SunCHECK's remote and device integration capabilities," said Jeff Simon, Sun Nuclear CEO.

Comprehensive Quality Management Solutions featured in the Sun Nuclear booth include:

  • SunCHECK Platform & Patient QA—New for SunCHECK, PlanCHECK automates the time-consuming task of plan checks. Plus, ArcCHECK direct device integration delivers expanded, flexible Pre-Treatment QA.
  • SRS, SBRT & SIMT QA — Within the SNC Patient software for SRS MapCHECK, a new QA Setup Tool simplifies the capture of multiple SRS targets. Also featured at ASTRO, MultiMet-WL Cube efficiently measures off-axis targets for multiple-met single-isocenter SRS treatments.
  • Patient Alignment — Explore the newest and most accurate laser solutions available, Sun Nuclear's Moveable Laser System, CT SIM+, and Fixed Laser System, MICRO+.
  • Machine QA — New SunCHECK Machine QA functionality in v3.1 expands capabilities to efficiently customize tasks and workflow, enabling new compliance with DIN Standards (Germany) and additional global protocols. Plus, SunCHECK integration of trusted arrays Daily QA 3 and IC PROFILER simplifies daily and monthly QA.
  • Modality Support — Discover solutions available for MRgRT, Proton, Adaptive, and CyberKnife programs.
  • Dosimetry — Achieve efficient, accurate water tank scanning with 3D SCANNER and SNC Dosimetry. For other dosimetry needs, Sun Nuclear offers trusted reference ion chambers.
  • Diagnostic QA — Experience Sun Nuclear's comprehensive QA solutions for CT, Mammography, Ultrasound, and DR/CR/Fluoroscopy.

For an in-depth 1:1 discussion of these solutions, attendees may schedule a demo during the meeting. Attendees are also encouraged to attend these lunchtime talks presented by our clinical experts:

  • Performing QA Remotely in the Age of COVID — October 26, 11:45 AM ESTJason Tracy, M.S., DABR, Sun Nuclear
  • Critical Components of a Stereotactic Radiosurgery/Radiotherapy Program — October 27, 12:30 PM ESTJennifer Hamilton, M.E., DABR, Sun Nuclear

For more details on Sun Nuclear's presence at ASTRO, visit sunnuclear.com/astro-2020.

Related Content

IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Strategies to help guide nuclear radiology teams at various healthcare systems in 2021 and beyond
Feature | Nuclear Imaging | September 16, 2021 | By Staff of the American Society of Nuclear Cardiology (ASNC)
A year after COVID-19 turned the world upside do
This is an example of 3-D ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

This is an example of TriVu ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

Feature | Breast Imaging | September 15, 2021 | By Jennifer Meade
The...
Revenues for teleradiology reading service providers are forecast to follow a similar profile over this period.

Outlook for 2021 and Beyond. As displayed in the figure below, these six market drivers are projected to result in teleradiology reading service volumes increasing by 21% in 2021 and nearly doubling by 2025. Revenues for teleradiology reading service providers are forecast to follow a similar profile over this period.

Feature | Teleradiology | September 15, 2021 | By Arun Gill
The closely tied relationship between...
To get more flexibility and cost savings from storage, healthcare organizations are increasing their investments in the cloud
Feature | Information Technology | September 15, 2021 | By Kumar Goswami
Healthcare organizations today are storing petabytes of medical imaging data — lab slides,...
Cloud services have been utilized within healthcare organizations for more than a decade. Now with the growth of artificial intelligence (AI) it is very common to see organizations adopting cloud services.

Getty Images

Feature | Information Technology | September 14, 2021 | By Jef Williams
Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.

Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.

Feature | Radiology Imaging | September 14, 2021 | By Brendon McHugh
As with all imaging technologies, COVID-19 is expected to continue to negatively impact the market.

Courtesy of Grand View Research

Feature | Magnetic Resonance Imaging (MRI) | September 14, 2021 | By Melinda Taschetta-Millane
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.